{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T10:13:39Z","timestamp":1701425619902},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"896","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The aim of this review is to identify current chemotherapy treatment for tumours of the oesophagus, stomach, pancreas, and liver. The role of both neoadjuvant, adjuvant, and palliative chemotherapy regimens will be discussed. This review will be of interest to oncologists in clarifying current issues regarding chemotherapy, and to physicians in other medical specialties, to increase their general understanding of benefits and drawbacks of chemotherapy in this patient group.<\/jats:p>","DOI":"10.1136\/pmj.76.896.321","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:38:40Z","timestamp":1027766320000},"page":"321-321","source":"Crossref","is-referenced-by-count":5,"title":["Chemotherapy for upper gastrointestinal tumours"],"prefix":"10.1093","volume":"76","author":[{"given":"A L","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Oncology, Leicester Royal Infirmary , Leicester LE1 5WW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"O'Byrne","sequence":"additional","affiliation":[{"name":"Department of Oncology, Leicester Royal Infirmary , Leicester LE1 5WW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W P","family":"Steward","sequence":"additional","affiliation":[{"name":"Department of Oncology, Leicester Royal Infirmary , Leicester LE1 5WW, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,6,1]]},"reference":[{"key":"2023042614132693200_B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-03432-3","volume-title":"TNM atlas: illustrated guide to the TNM\/pTNM classification of malignant tumours.","author":"Hermanek","year":"1997","edition":"4th Ed."},{"key":"2023042614132693200_B2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1023\/A:1008273110272","article-title":"Oesophageal cancer treatment: studies, strategies and facts.","volume":"9","author":"Wobst","year":"1998","journal-title":"Ann Oncol"},{"key":"2023042614132693200_B3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0360-3016(89)90011-4","article-title":"Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial.","volume":"16","author":"Roussel","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023042614132693200_B4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus.","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"2023042614132693200_B5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for oesophageal adenocarcinoma.","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"2023042614132693200_B6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0167-8140(84)80058-4","article-title":"Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study.","volume":"2","author":"Anderson","year":"1984","journal-title":"Radiother Oncol"},{"key":"2023042614132693200_B7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JCO.1990.8.1.119","article-title":"Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.","volume":"8","author":"Forastiere","year":"1990","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1200\/JCO.1987.5.4.622","article-title":"Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037).","volume":"5","author":"Poplin","year":"1987","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/107327489900600107","article-title":"Palliation of dysphagia of esophageal cancer by endoscopic lumen restoration techniques.","volume":"6","author":"Boyce","year":"1999","journal-title":"Cancer Control: Journal of the Moffitt Cancer Center"},{"key":"2023042614132693200_B10","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jnci\/86.14.1086","article-title":"Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.","volume":"86","author":"Ajani","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"2023042614132693200_B11","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.1990.8.8.1362","article-title":"A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer.","volume":"8","author":"Coombes","year":"1990","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1200\/JCO.1993.11.8.1441","article-title":"Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.","volume":"11","author":"Hermans","year":"1993","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(94)92464-3","article-title":"The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: a five year follow-up.","volume":"343","author":"Hallissey","year":"1994","journal-title":"Lancet"},{"key":"2023042614132693200_B14","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1200\/JCO.1998.16.8.2733","article-title":"Adjuvant intraperitoneal chemotherapy with carbon-absorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology.","volume":"16","author":"Rosen","year":"1998","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B15","first-page":"215","article-title":"A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer.","volume":"15","author":"Kang","year":"1996","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"2023042614132693200_B16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF01658939","article-title":"Neoadjuvant chemotherapy for high-grade advanced gastric cancer.","volume":"17","author":"Yonemura","year":"1993","journal-title":"World J Surg"},{"key":"2023042614132693200_B17","first-page":"1021","volume-title":"Cancer: principles and practice of oncology.","author":"Alexander","year":"1997","edition":"5th Ed."},{"key":"2023042614132693200_B18","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/JCO.1991.9.5.827","article-title":"Sequential high-dose methotrexate and fluorouracil combined with doxorubicin: a step ahead in the treatment of gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Co-operative Group.","volume":"9","author":"Wils","year":"1991","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1997.15.1.261","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.","volume":"15","author":"Webb","year":"1997","journal-title":"J Clin Oncol"},{"issue":"S8","key":"2023042614132693200_B20","first-page":"1272","article-title":"CEF chemotherapy for advanced gastro-oesophageal cancer.","volume":"33","author":"Lacko","year":"1997","journal-title":"Eur J Cancer"},{"key":"2023042614132693200_B21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00000658-199705000-00018","article-title":"Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival.","volume":"225","author":"Yeo","year":"1997","journal-title":"Ann Surg"},{"key":"2023042614132693200_B22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(69)92326-5","article-title":"Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable cancer.","volume":"ii","author":"Moertel","year":"1969","journal-title":"Lancet"},{"key":"2023042614132693200_B23","first-page":"205","article-title":"A multi-institutional comparative trial of radiation therapy alone and in combination with 5-FU for locally unresectable pancreatic carcinoma.","volume":"189","author":"Gastrointestinal Tumour Study Group","year":"1979","journal-title":"Ann Surg"},{"key":"2023042614132693200_B24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.1985.3.3.373","article-title":"Treatment of locally unresectable cancer of the stomach and pancreas: an Eastern Cooperative Oncology Group study.","volume":"3","author":"Klaasen","year":"1985","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1136\/bmj.281.6255.1589","article-title":"Chemotherapy in pancreatic cancer: results of a controlled prospective, randomised, multicentre trial.","volume":"281","author":"Mallinson","year":"1980","journal-title":"BMJ"},{"key":"2023042614132693200_B26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/bjs.1800810629","article-title":"Chemotherapy prolongs survival in inoperable pancreatic carcinoma.","volume":"81","author":"Palmer","year":"1994","journal-title":"Br J Surg"},{"key":"2023042614132693200_B27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/oxfordjournals.annonc.a058495","article-title":"Phase II study of cisplatin and 120 hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma.","volume":"4","author":"Rougier","year":"1993","journal-title":"Ann Oncol"},{"key":"2023042614132693200_B28","first-page":"1050","article-title":"Efficacy of 5FU+cisplatin (FUP) compared to bolus 5FU (FU) in advanced pancreatic carcinoma (APC): a randomized trial from the French Anticancer Centers Digestive Group (FNLCCDG).","volume":"18","author":"Rougier","year":"1999","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"2023042614132693200_B29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/bjs.1800800341","article-title":"Clinical trial of tamoxifen in patients with irresectable pancreatic adenocarcinoma.","volume":"80","author":"Taylor","year":"1993","journal-title":"Br J Surg"},{"key":"2023042614132693200_B30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1136\/bmj.316.7149.1935","article-title":"Effect of flutamide on survival in patients with pancreatic cancer: results of a prospective, randomised, double-blind, placebo controlled trial.","volume":"316","author":"Greenway","year":"1998","journal-title":"BMJ"},{"key":"2023042614132693200_B31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00873144","article-title":"Phase II trial of ZD1694 (Tomudex (tm)) in patients with advanced pancreatic cancer.","volume":"13","author":"Pazdur","year":"1996","journal-title":"Investigational New Drugs"},{"key":"2023042614132693200_B32","first-page":"221","article-title":"Docetaxel, a potentially active agent for patients with pancreatic adenocarcinoma.","volume":"14","author":"Abbruzzese","year":"1995","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"key":"2023042614132693200_B33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00873232","article-title":"Phase II study of gemcitabine (2\u2032,2\u2032-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.","volume":"12","author":"Casper","year":"1994","journal-title":"Investigational New Drugs"},{"key":"2023042614132693200_B34","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"2023042614132693200_B35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a010600","article-title":"A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.","volume":"7","author":"Rothenberg","year":"1996","journal-title":"Ann Oncol"},{"key":"2023042614132693200_B36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(88)90007-2","article-title":"Clinical trials in primary hepatocellular carcinoma: current status and future directions.","volume":"15","author":"Nerenstone","year":"1988","journal-title":"Cancer Treatment Reviews"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/76\/896\/321\/50044637\/postgradmedj-76-321.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/76\/896\/321\/50044637\/postgradmedj-76-321.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T14:47:13Z","timestamp":1682520433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/76\/896\/321\/7040077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6,1]]},"references-count":36,"journal-issue":{"issue":"896","published-online":{"date-parts":[[2000,6,1]]},"published-print":{"date-parts":[[2000,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pmj.76.896.321","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,6]]},"published":{"date-parts":[[2000,6,1]]}}}